These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35493093)

  • 21. A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma.
    Song J; Liu Y; Guan X; Zhang X; Yu W; Li Q
    Front Mol Biosci; 2021; 8():675193. PubMed ID: 34291083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma.
    Wang Z; Cheng Z; Lu S; Chard Dunmall LS; Wang J; Guo Y; Wang Y
    Front Immunol; 2022; 13():896627. PubMed ID: 35812448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma.
    Du F; Dong D; Zhang X; Jia J
    Technol Cancer Res Treat; 2021; 20():15330338211052142. PubMed ID: 34761715
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment.
    Li R; Huang B; Tian H; Sun Z
    Front Oncol; 2022; 12():1096717. PubMed ID: 36698392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune-Related Long Non-coding RNA Signature and Clinical Nomogram to Evaluate Survival of Patients Suffering Esophageal Squamous Cell Carcinoma.
    Zhu T; Ma Z; Wang H; Wei D; Wang B; Zhang C; Fu L; Li Z; Yu G
    Front Cell Dev Biol; 2021; 9():641960. PubMed ID: 33748133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
    Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
    Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets.
    Song D; Wei Y; Hu Y; Sun Y; Liu M; Ren Q; Hu Z; Guo Q; Wang Y; Zhou Y
    Clin Transl Oncol; 2022 Jun; 24(6):1100-1114. PubMed ID: 35098447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
    BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma.
    Wang X; Wu S; Liu F; Ke D; Wang X; Pan D; Xu W; Zhou L; He W
    Front Immunol; 2021; 12():781466. PubMed ID: 34868055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Molecular Subtypes Associated with PCD in Esophageal Squamous Cell Carcinoma and Analysis of Immune Microenvironment.
    Chen M; Qi Y; Zhang S; Du Y; Cheng H; Gao S
    Curr Med Chem; 2024 May; ():. PubMed ID: 38738730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Stratification and Validation of Eleven Autophagy-Related lncRNAs for Esophageal Squamous Cell Carcinoma.
    Zhao X; Wang Y; Meng F; Liu Z; Xu B
    Front Genet; 2022; 13():894990. PubMed ID: 35832188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma.
    Su R; Cai L; Xiong P; Liu Z; Chen S; Liu X; Lin R; Lei Z; Tian D; Su M
    J Inflamm Res; 2022; 15():1437-1456. PubMed ID: 35250293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of immunogenic cell death-applied prediction model for esophageal carcinoma.
    Wen Y; You D; Bai Y; Cao J; Zhang L; Xia X
    Am J Cancer Res; 2023; 13(5):2104-2115. PubMed ID: 37293167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.
    Zhao F; Gao S; Qin X; Niu R; Li Z; Wang C; Li S
    Front Cell Dev Biol; 2022; 10():820870. PubMed ID: 35309940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy.
    Liao X; Liu H; Zhang Z; Zhang J; Zhang C; Zhao W
    Front Genet; 2022; 13():1010787. PubMed ID: 36338964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study.
    Li K; Lin Y; Luo Y; Xiong X; Wang L; Durante K; Li J; Zhou F; Guo Y; Chen S; Chen Y; Zhang D; Yeung SJ; Zhang H
    Mol Cancer; 2022 Jan; 21(1):21. PubMed ID: 35042519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.